Lumeda

Rocky Hill, United States Founded: 2020 • Age: 6 yrs
Photodynamic therapy device for lung cancer treatment is developed.

About Lumeda

Lumeda is a company based in Rocky Hill (United States) founded in 2020 by Paul E Sanders and Trevor MacDougall.. Lumeda has raised $5.34 million across 2 funding rounds from investors including Connecticut Innovations and Cycle Capital. The company has 10 employees as of December 31, 2022. Lumeda offers products and services including DigiLum™. Lumeda operates in a competitive market with competitors including Pulmonx, PhotoPharmics, Neurent Medical, Gradient Denervation Technologies and Spiration, among others.

  • Headquarter Rocky Hill, United States
  • Employees 10 as on 31 Dec, 2022
  • Founders Paul E Sanders, Trevor MacDougall
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Lumeda Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.34 M (USD)

    in 2 rounds

  • Latest Funding Round
    $4.3 M (USD), Series A

    Feb 01, 2021

  • Investors
  • Employee Count
    10

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Lumeda

Lumeda offers a comprehensive portfolio of products and services, including DigiLum™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

System for precise light dosing in treating solid tumors like lung cancer.

People of Lumeda
Headcount 1-10
Employee Profiles 3
Board Members and Advisors 6
Employee Profiles
People
Krenar Tasimi
Senior Electrical Engineer
People
Paul E. Sanders
Founder
People
Marc LaPierre
Senior Quality Manager

Unlock access to complete

Board Members and Advisors
people
Justin D. Blasberg
Scientific Advisor
people
Michael M. Conway
Scientific Advisor
people
Gal Shafirstein
Scientific Advisor
people
Sandra Gollnick
Scientific Advisor

Unlock access to complete

Funding Insights of Lumeda

Lumeda has successfully raised a total of $5.34M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $4.3 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $4.3M
  • First Round

    (04 Jun 2020)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2021 Amount Series A - Lumeda Valuation Connecticut Innovations
Jun, 2020 Amount Seed - Lumeda Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Lumeda

Lumeda has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Connecticut Innovations and Cycle Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
Founded Year Domain Location
Cycle Capital is engaged in venture capital for clean tech innovations.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Lumeda

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Lumeda

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Lumeda Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Lumeda

Lumeda operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pulmonx, PhotoPharmics, Neurent Medical, Gradient Denervation Technologies and Spiration, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of smart devices for treating pulmonary diseases
domain founded_year HQ Location
Non-invasive phototherapy for Parkinson's disease is developed.
domain founded_year HQ Location
Smart devices for minimally invasive rhinitis treatment are developed.
domain founded_year HQ Location
Endovascular catheter-based technology for pulmonary hypertension treatment is provided.
domain founded_year HQ Location
IntraBronchial Valve to treat lung disease
domain founded_year HQ Location
Minimally invasive devices for brain tumor treatment are provided.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Lumeda

When was Lumeda founded?

Lumeda was founded in 2020.

Where is Lumeda located?

Lumeda is headquartered in Rocky Hill, United States. It is registered at Rocky Hill, Connecticut, United States.

Who is the current CEO of Lumeda?

Alexander Zinke is the current CEO of Lumeda.

Is Lumeda a funded company?

Lumeda is a funded company, having raised a total of $5.34M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.04M, raised on Jun 04, 2020.

How many employees does Lumeda have?

As of Dec 31, 2022, the latest employee count at Lumeda is 10.

What does Lumeda do?

Lumeda was founded in 2020 and is based in Rocky Hill, United States. A photodynamic therapy device is developed by the company for lung cancer treatment within the medical device sector. Optical technology is utilized, along with photonics instrumentation and proprietary software, to automate light delivery to tumors and manage dosimetry profiles. Operations focus on advancing targeted oncology solutions through automated PDT applications.

Who are the top competitors of Lumeda?

Lumeda's top competitors include Pulmonx, PhotoPharmics and Neurent Medical.

What products or services does Lumeda offer?

Lumeda offers DigiLum™.

Who are Lumeda's investors?

Lumeda has 2 investors. Key investors include Connecticut Innovations, and Cycle Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available